上市公司：创远信科（831961），奥迪威（832491），同惠电子（833509），海能技术（430476），新 芝生物（430685），基康仪器（830879），天罡股份（832651），驰诚股份（834407），莱赛激光 （871263） 2016-2025年1-10月仪器仪表制造业企业数统计图 数据来源：国家统计局，智研咨询整理 知前沿，问智研。智研咨询是中国一流产业咨询机构，十数年持续深耕产业研究领域，提供深度产业研 究报告、商业计划书、可行性研究报告及定制服务等一站式产业咨询服务。专业的角度、品质化的服 务、敏锐的市场洞察力，专注于提供完善的产业解决方案，为您的投资决策赋能。 相关报告：智研咨询发布的《2026-2032年中国仪器仪表市场供需预测及未来发展趋势报告》 2025年1-10月，仪器仪表制造业企业数（以下数据涉及的企业，均为规模以上工业企业，从2011年起， 规模以上工业企业起点标准由原来的年主营业务收入500万元提高到年主营业务收入2000万元）为7664 个，和上年同期相比，增加了391个，同比增长5.38%，占工业总企业的比重为1.46%。 ...

Group 1 - The first batch of eight actively managed theme funds on the Beijing Stock Exchange (BSE) is set to enter its second open period, with an average cumulative return of nearly 100% over the past two years, outperforming major indices such as the ChiNext 50 and the BSE 50 by 50% [3][6][8] - As of December 5, 2025, the average cumulative return of these eight theme funds since inception is 62.31%, with some funds achieving returns exceeding 100%, the highest being 138% [3][6][7] - The total market value of publicly offered funds' heavy holdings in BSE stocks has shown a rising trend, surpassing 10 billion yuan in Q3 2025, indicating a more diversified investment approach [3][8] Group 2 - The BSE market has seen the issuance of 33 BSE 50 index funds, with a total scale of 13.3 billion yuan as of December 5, 2025, reflecting a steady growth in passive index fund offerings [10][11] - The overall price-to-earnings (PE) ratio of BSE A-shares remains at 44X, with daily trading volume averaging 13.9 billion yuan, indicating a stable market environment [20][23] - The BSE 50 index has reported a weekly increase of 1.49%, closing at 1,408.34 points, while the overall sentiment in the A-share market remains cautious amid upcoming significant meetings [17][25] Group 3 - The BSE has witnessed a total of 47 companies listed from January 1, 2024, to December 5, 2025, with one new company, Jingchuang Electric, listed in the week of December 1, 2025 [26][27] - The average issuance PE ratio for newly listed companies in 2024 is 13.79X, with an average first-day price fluctuation of 288% [12][13]

Core Viewpoint - The manufacturing sector in China has shown growth in the number of enterprises, indicating a positive trend in industrial development and investment opportunities [1] Group 1: Manufacturing Sector Overview - As of January to October 2025, the number of manufacturing enterprises reached 487,309, an increase of 13,423 compared to the same period last year, representing a year-on-year growth of 2.83% [1] - Manufacturing enterprises account for 93.1% of the total industrial enterprises, highlighting their significant role in the industrial landscape [1] Group 2: Industry Reports and Insights - The report titled "2026-2032 China Manufacturing Market Competition Pattern Analysis and Investment Development Research Report" by Zhiyan Consulting provides in-depth analysis and insights into the manufacturing sector [1] - Zhiyan Consulting is recognized as a leading industry consulting firm in China, specializing in comprehensive industry research reports, business plans, feasibility studies, and customized services [1]

Group 1 - The core point of the article highlights that the Huatai-PineBridge North Exchange Innovation Selected Two-Year Open Mixed Fund A/C has performed poorly in November, with returns of -13.50% and -13.52%, ranking at the bottom of the mixed fund performance list for the month [1] - As of the latest report, the fund has a cumulative return of 96.74% and 93.60%, with a cumulative net asset value of 1.9405 yuan and 1.9095 yuan respectively [1] - The fund focuses on companies with excellent management quality and favorable fundamental trends that align with China's economic and industrial development direction, with its top ten holdings including companies like Kaitian Co., Minshida, and Wantong Hydraulic [1] Group 2 - The current fund manager, Ma Xiang, has been with Huatai-PineBridge since 2011 and has served as an industry analyst before taking on the role of fund manager since November 23, 2021 [1] - The fund was established on November 23, 2021, and has a total fund size of 1.88 billion yuan for the C share and 1.91 billion yuan for the A share as of the end of November 2023 [2]

Core Insights - The report indicates a significant adjustment in the market during November 2025, with the North Exchange 50 Index declining by 12.32% and the North Exchange Specialized and New Index falling by 13.44%, underperforming compared to major indices like the ChiNext and STAR Market [8][10][12] - Looking ahead to December, the report emphasizes the importance of focusing on trading opportunities related to companies included in the North Exchange 50 and Specialized and New Indexes, particularly after the resolution of certain uncertainties [3][21] - The report anticipates a speeding up of reforms in the North Exchange in 2026, suggesting that recent market adjustments may have led to the undervaluation of quality assets, creating potential investment opportunities [3][21] Market Performance - The North Exchange A-share overall PE ratio remains at 44X, while the daily average trading volume has decreased to 139 billion [28][31] - In November 2025, the North Exchange saw a trading volume increase to approximately 376.6 billion, with a monthly turnover rate of 53%, up from 44% in October [20][23] - The report notes that only 10 companies had a price increase exceeding 5% in November, with notable performers in the power equipment and machinery sectors [17][18] Company Focus - Companies such as Tongli Co., Development Technology, and others are highlighted as potential investment targets due to their solid fundamentals and valuation attractiveness [3][21] - The report suggests focusing on companies with stable long-term performance and market scarcity, such as Guangxin Technology and Lin Tai New Materials [3][21] - Sectors with high policy support and growth certainty, including robotics, energy storage, and AI power, are recommended for investment, with specific companies like Hai Xi Communications and Xingtu Measurement Control being noted [3][21] New Listings and IPOs - From January 1, 2024, to November 28, 2025, a total of 46 companies have been newly listed on the North Exchange, with the average issuance PE ratio being 13.80X and an average first-day price fluctuation of 287% [37][45] - Recent updates indicate that two companies have registered and two have passed the review process, with ongoing normalization in new stock issuance [43][44]

证券代码：920476 证券简称：海能技术 公告编号：2025-136 海能未来技术集团股份有限公司 关于控股子公司获得发明专利证书的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 授权公告号：CN 116988692 B 二、对公司的影响 上述发明专利主要应用于公司的全自动实验室清洗机产品。公司的全自动 实验室清洗机产品可广泛应用于实验室玻璃、塑料、橡胶等多元材质器皿的清洗， 可满足制药类实验室 ppb 分析级洁净度及结果可验证、科研/公安/医学实验室 规避交叉污染和提高实验数据可靠性、石化实验室高防爆高防腐、粮油/食品/化 妆品实验室可定制流程及高效清洗等不同行业及领域实验室的要求。公司控股 子公司获得上述专利，实现了其实验室清洗设备核心技术的完全自主可控，有利 于巩固其在智能实验室清洗设备领域的技术优势，为其后续产品迭代开发及市 场拓展奠定知识产权护城河。 三、备查文件 一、基本情况 海能未来技术集团股份有限公司（以下简称"公司"）的控股子公司白小白 科技（山东）有限公司近日收到国家知识产权 ...

Group 1 - Xiaopeng Motors recently released the humanoid robot IRON, which mimics human gait and has attracted significant attention [2][6] - The humanoid robot market in China is expected to reach a scale of 2 to 5 billion yuan by 2028 [2][6] - The humanoid robot industry is characterized by three main features: anthropomorphic intelligence, human-like form, and wide applicability [2][19] Group 2 - The median price-to-earnings (P/E) ratio for the electronic equipment industry on the Beijing Stock Exchange (BSE) has decreased from 60.5X to 60.1X [49][50] - The total market capitalization of the electronic equipment industry has declined from 146.14 billion yuan to 144 billion yuan [49][50] - The median P/E ratio for the mechanical equipment industry has decreased from 48.9X to 47.5X [52][53] Group 3 - The BSE includes 13 companies in the humanoid robot industry chain, with key players such as Kaite Co., which focuses on developing electronic mechanical brake sensors and other products [41][42] - Dingzhi Technology is involved in the development of hollow cup motors and precision gearboxes, while other companies like Audiwei and Huami New Materials are also making strides in the humanoid robot sector [41][42] - The humanoid robot market is projected to grow significantly, with estimates suggesting a market size of 500 billion to 3 trillion yuan by 2035 [40][41]

Group 1 - The report highlights that the Beijing Stock Exchange (BSE) has entered a new phase of "quality improvement and efficiency enhancement" in the M&A market, driven by corporate development and policy guidance [6][21]. - The number of M&A events in 2023 and 2024 significantly increased, reaching 69 and 75 respectively, compared to only 30 in 2022, indicating a robust growth trend [6][21]. - The report notes that the total number of M&A events over four years reached 219, excluding failed cases, with a marked increase in transaction amounts [3][6]. Group 2 - In the recent period, 30 new M&A transactions exceeding 100 million yuan were disclosed, totaling 18.1 billion yuan, with significant projects in emerging industries such as new energy and biomedicine [3][4]. - The report identifies key companies involved in M&A activities, such as Dingzhi Technology and Haineng Technology, which have been actively pursuing horizontal and vertical integration within their respective industries [14][17]. - The report emphasizes that the BSE's M&A activities are increasingly focused on vertical expansion, business upgrades, and market expansion, particularly in high-growth sectors like intelligent manufacturing and new energy [18][21]. Group 3 - Dingzhi Technology has completed nine M&A transactions from 2023 to 2025, primarily focusing on enhancing its supply capabilities through strategic acquisitions [14][15]. - Haineng Technology has engaged in six M&A transactions since its listing, mainly expanding its product categories in the scientific instrument sector [17][18]. - The report indicates that the BSE's M&A market is characterized by a focus on technology innovation and industry chain integration, which is expected to continue driving high-quality development for listed companies [21].

Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Views - The company plans to invest 21 million yuan in Anypu to enhance its high-end product matrix and strategically enter the mass spectrometry market, which is a key segment in the domestic scientific instrument industry [5][6] - The mass spectrometry market is currently dominated by developed countries, with 90% of the global market share, and China has an annual import scale of approximately 10 billion yuan for mass spectrometers [6] - The company has launched the N70 Fourier Transform Near-Infrared Spectrometer, which is expected to drive incremental sales and has established a research institute in collaboration with Xi'an Jiaotong University for the development of cell membrane chromatography products [6] - The company is increasing its investment in overseas markets, with its subsidiary G.A.S. developing methods for detecting siloxane content in biogas power generation, which has already become a standard detection method in the U.S. [6] Financial Summary - The company expects to achieve a net profit of 0.50 billion yuan in 2025, with projected profits of 0.63 billion yuan in 2026 and 0.80 billion yuan in 2027, corresponding to P/E ratios of 43, 34, and 27 times respectively [6][8] - Revenue is projected to grow from 3.10 billion yuan in 2024 to 5.26 billion yuan in 2027, with a compound annual growth rate of approximately 20.21% [8][10] - The company’s return on equity (ROE) is expected to improve from 2.77% in 2024 to 12.03% in 2027, indicating enhanced profitability [8][10]

Core Viewpoint - Haineng Technology plans to invest 21 million yuan in Anyipu (Suzhou) Medical Technology Co., Ltd. through a combination of equity transfer and capital increase, aiming to enhance its business layout in the mass spectrometry product sector [3][4]. Investment Details - The investment consists of two parts: 7 million yuan for acquiring 1.6393% equity from existing shareholders and 14 million yuan for subscribing to the new registered capital of 19.3688 million yuan [3][4]. - After the transaction, Haineng Technology is expected to hold 3.85% of Anyipu's equity [3][4]. Financial Overview of Anyipu - Anyipu, established in March 2021, focuses on the R&D, production, and sales of mass spectrometers, with applications in semiconductor testing, biomedicine, food safety, and environmental monitoring [4][5]. - Financial projections indicate that Anyipu will achieve a revenue of 41.8749 million yuan in 2024 and 35.2890 million yuan from January to September 2025, with total assets of 120 million yuan and net assets of 103 million yuan as of September 2025 [4][5]. Shareholding Structure - Prior to the capital increase, Anyipu's registered capital was 8.4392 million yuan, which is expected to rise to 8.6329 million yuan post-investment [5]. - Zhang Xiaohua remains the largest shareholder, increasing his stake from 38.37% to 40.69% after the capital increase, while Haineng Technology will hold 3.85% [5][6]. Strategic Importance - This investment is a significant move for Haineng Technology to establish a foothold in the mass spectrometry market, which is experiencing strong demand in strategic emerging sectors such as semiconductors and biomedicine [6][7]. - The collaboration is expected to create synergies in technology R&D, manufacturing, and sales channels, enhancing overall market competitiveness [6][7].